Why T2 Biosystems Shares Are Nosediving

T2 Biosystems Inc (NASDAQ: TTOO) shares are trading lower by 21.43% to $1.10 Tuesday morning after the company announced a proposed public offering. What Else?

byHenry Khederian

February 14, 2023

1 minute read

T2 Biosystems Inc (NASDAQ:TTOO) shares are trading lower by 21.43% to $1.10 Tuesday morning after the company announced a proposed public offering.

What Else?

All of the securities are being offered by T2 Biosystems. The offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.

See Also: T2 Biosystems Touts Positive Results From T2Biothreat Panel Stud

Craig-Hallum Capital Group LLC is acting as the sole managing underwriter for the offering.

According to data from Benzinga Pro, TTOO has a 52-week high of $29.25 and a 52-week low of $1.05.

More Than Vaccines: Tonix Programs Address the Spectrum of Covid-19 Problems from Prevention, to Infection to Post-Viral Syndrome

Today, 1:21 PM

The following article is sponsored by the clinical communications unit of Redington, Inc., which is paid by Tonix Pharmaceuticals Holding Corp. to provide investor communications services. The information contained in this article in no way represents investment advice or opinion on the part of Benzinga or its writers and is intended for informational purposes only.

JNJ

Mannatech Q3 EPS $1.44 Up From $0.76 YoY, Sales $39.40M Up From $37.97M YoY

By Benzinga Newsdesk

Today, 1:21 PM

Mannatech (NASDAQ:MTEX) reported quarterly earnings of $1.44 per share. This is a 89.47 percent increase over earnings of $0.76 per share from the same period last year. The company reported $39.40 million in sales this

MTEX